Round Type
Funding Round
Description
VANCOUVER, BC / May 6, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed the second tranche of a non-brokered private placement. The Company accepted subscriptions for 2,375,000 units at a price of $0.02 per unit, for gross proceeds of $47,500. Each unit consists of one common share and one common share purchase warrant
Who else raised in Food And Beverage and Health Care around the same time
Companies in the same sectors as Love Pharma that raised within 45 days of this round, from Fundz verified event records.
- UPSIDE Foods raised $400M on May 5, 2022.
- UPSIDE Foods raised $400M (Series C) on April 21, 2022.
- Sun Life Financial raised $2M (Seed) on April 18, 2022.
- The Valens Company raised an undisclosed amount (Funding Round) on April 5, 2022.
- Flow Control Holdings raised an undisclosed amount (Private Equity) on April 5, 2022.
- Astaria Global raised $8M (Seed) on June 20, 2022.
Who to call at Love Pharma, and when
A new round usually means Love Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Love Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Love Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Love Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Love Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Love Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.